MYC is a master regulator of cell survival in immune cells, and its overexpression is frequently observed in aggressive forms of lymphoma, such as diffuse large B cell lymphoma (DLBCL) and PCNSL (46). This evidence concerns the gene MYC and diffuse large B-cell lymphoma.